Seijgraaf voor Tesseract

Seijgraaf BV (Board Director IHC Switzerland), partners HEAP Research BV (Board Director PPi Healthcare Consulting Ltd UK ) and MArS Market Access & Pricing Strategy GmbH are specialized in the field of healthcare, in particular issues of market access and reimbursement of (innovative) health technology such as pharmaceuticals, medical devices, e-health products and surgical and other medical interventions.

Seijgraaf and partners are  focusing on the comprehensive downstream process of strategy development, regulatory and market access support. The combination of our companies allows us to cover all aspects of the market access process of regulatory and reimbursement and enables us to provide a comprehensive service package to Medtech companies.

For a successful market introduction of a Medtech product, it’s important that this fits into a statutory reimbursement system. As reimbursement processes have not been harmonized across the European Union (EU), the development of pan-European reimbursement strategy for medical devices and pharmaceuticals is an important deliverable and strategy development is the prime initial focus. Developing strategy involves knowledge of in country-specific parameters. Knowing how to interpret the rules, codes and procedures for the development and the reimbursement of innovative Medtech products is critical when entering a new market. An early  reimbursement scan can provide manufacturers  with necessary information for selecting the right reimbursement target market.


In recent years, we have expanded our network throughout the EU. We have built an extensive network of reimbursement and in-market expertise of market access consultants throughout the EU and in fact all 27 markets and the UK are represented as well as many Eastern European markets.

It is our daily work to support Medtech companies, during pan-European market access procedures and the introduction of healthcare services and concepts on the EU market. We focus on strategy development, reimbursement processes, implementation and project management.

Stretching over a period of more than 35 years we have supported Medtech companies in matters of market access in the field of pharma, medical technology, healthcare providers and governmental organizations.

Because of our knowledge and our experience, we’re able to advice and to provide guidance throughout the process: from product development to the eventual market entrance, and all phases in between. Together with the manufacturers or distributors, we develop and execute the best strategy for a successful market introduction of any innovative Medtech product.